CONTER, VALENTINO
CONTER, VALENTINO
Eight-year national multicenter experience on the use of glucarpidase as effective rescue therapy for delayed methotrexate elimination after high-dose methotrexate cycles administered in children with hemato-oncological diseases
2025 Peccatori, N; Coppola, M; Colombini, A; Silvestri, D; Bertorello, N; Kiren, V; Melchionda, F; Mura, R; Onofrillo, D; Gobbi, S; Mattera, R; Vinti, L; Casini, T; Santoro, N; Sperli, D; D'Ippolito, C; Conter, V; Biondi, A; Rizzari, C
A Hematopoietic Stem Cell Transplantation Startup in Iraqi Kurdistan: Results in Thalassemia Patients and Analysis of the Methodology
2023 Verna, M; Canesi, M; Conter, V; Faulkner, L; Rovelli, A; Silvestri, D; Majolino, I; Biondi, A; Nawfal Abdullah, C; Faeq Mohammed, V
Bone Marrow Stromal Cell Regeneration Profile in Treated B-Cell Precursor Acute Lymphoblastic Leukemia Patients: Association with MRD Status and Patient Outcome
2022 Oliveira, E; Costa, E; Ciudad, J; Gaipa, G; Sedek, Ł; Barrena, S; Szczepanski, T; Buracchi, C; Silvestri, D; Siqueira, P; Mello, F; Torres, R; Oliveira, L; Fay-Neves, I; Sonneveld, E; van der Velden, V; Mejstrikova, E; Ribera, J; Conter, V; Schrappe, M; van Dongen, J; Land, M; Orfao, A
FLT3-ITD in Children with Early T-cell Precursor (ETP) Acute Lymphoblastic Leukemia: Incidence and Potential Target for Monitoring Minimal Residual Disease (MRD)
2022 Locatelli, F; Lo Nigro, L; Andriano, N; Buldini, B; Silvestri, D; Villa, T; Parasole, R; Barisone, E; Testi, A; Biondi, A; Valsecchi, M; Rizzari, C; Conter, V; Basso, G; Cazzaniga, G
Minimal residual disease in BCR::ABL1-positive acute lymphoblastic leukemia: different significance in typical ALL and in CML-like disease
2022 Zuna, J; Hovorkova, L; Krotka, J; Koehrmann, A; Bardini, M; Winkowska, L; Fronkova, E; Alten, J; Koehler, R; Eckert, C; Brizzolara, L; Trkova, M; Stuchly, J; Zimmermann, M; De Lorenzo, P; Valsecchi, M; Conter, V; Stary, J; Schrappe, M; Biondi, A; Trka, J; Zaliova, M; Cazzaniga, G; Cario, G
Osteonecrosis in paediatric acute lymphoblastic leukaemia: Incidence, risk factors, radiological patterns and evolution in a single-centre cohort
2022 Brivio, E; Cossio, A; Borra, D; Silvestri, D; Prunotto, G; Colombini, A; Verna, M; Rizzari, C; Biondi, A; Conter, V; Valsecchi, M; Balduzzi, A
PAX5 fusion genes are frequent in poor risk childhood acute lymphoblastic leukaemia and can be targeted with BIBF1120
2022 Fazio, G; Bresolin, S; Silvestri, D; Quadri, M; Saitta, C; Vendramini, E; Buldini, B; Palmi, C; Bardini, M; Grioni, A; Rigamonti, S; Galbiati, M; Mecca, S; Savino, A; Peloso, A; Tu, J; Bhatia, S; Borkhardt, A; Micalizzi, C; Lo Nigro, L; Locatelli, F; Conter, V; Rizzari, C; Valsecchi, M; Te Kronnie, G; Biondi, A; Cazzaniga, G
Pre-existing antibodies against polyethylene glycol reduce asparaginase activities on first administration of pegylated E. coli asparaginase in children with acute lymphocytic leukemia
2022 Khalil, A; Wurthwein, G; Golitsch, J; Hempel, G; Fobker, M; Gerss, J; Moricke, A; Zimmermann, M; Smisek, P; Zucchetti, M; Nath, C; Attarbaschi, A; Von Stackelberg, A; Gokbuget, N; Rizzari, C; Conter, V; Schrappe, M; Boos, J; Lanvers-Kaminsky, C
Droplet Digital PCR Improves IG-/TR-based MRD Risk Definition in Childhood B-cell Precursor Acute Lymphoblastic Leukemia
2021 Della Starza, I; Nunes, V; Lovisa, F; Silvestri, D; Cavalli, M; Garofalo, A; Campeggio, M; De Novi, L; Soscia, R; Oggioni, C; Mussolin, L; Biondi, A; Guarini, A; Valsecchi, M; Conter, V; Biffi, A; Basso, G; Foà, R; Cazzaniga, G
Musculoskeletal manifestations of childhood cancer and differential diagnosis with juvenile idiopathic arthritis (ONCOREUM): a multicentre, cross-sectional study
2021 Civino, A; Alighieri, G; Prete, E; Caroleo, A; Magni-Manzoni, S; Vinti, L; Romano, M; Santoro, N; Filocamo, G; Belotti, T; Santarelli, F; Gorio, C; Ricci, F; Colombini, A; Pastore, S; Cesaro, S; Barone, P; Verzegnassi, F; Olivieri, A; Ficara, M; Miniaci, A; Russo, G; Gallizzi, R; Pericoli, R; Breda, L; Mura, R; Podda, R; Onofrillo, D; Lattanzi, B; Tirtei, E; Maggio, M; De Santis, R; Consolini, R; Arlotta, A; La Torre, F; Mainardi, C; Pelagatti, M; Coassin, E; Capolsini, I; Burnelli, R; Tornesello, A; Soscia, F; De Fanti, A; Rigante, D; Pizzato, C; De Fusco, C; Abate, M; Roncadori, A; Rossi, E; Stabile, G; Biondi, A; Lepore, L; Conter, V; Rondelli, R; Pession, A; Ravelli, A; Amatruda, M; Atzeni, C; Bertolini, P; Bigucci, B; Caniglia, M; Cappella, M; Cattalini, M; Cefalo, M; Cellini, M; Cortis, E; Davi, S; De Benedetti, F; Di Cataldo, A; Fabbri, E; Fagioli, F; Fontanili, I; Garaventa, A; Gicchino, M; Ladogana, S; Locatelli, F; Magnolato, A; Marsili, M; Martino, S; Mascarin, M; Messina, C; Micalizzi, C; Porta, F; Rizzari, C
Recurrent genetic fusions redefine MLL germ line acute lymphoblastic leukemia in infants
2021 Fazio, G; Bardini, M; De Lorenzo, P; Grioni, A; Quadri, M; Pedace, L; Corral Abascal, L; Palamini, S; Palmi, C; Buldini, B; Vinti, L; Parasole, R; Barisone, E; Zecca, M; Favre, C; Locatelli, F; Conter, V; Rizzari, C; Valsecchi, M; Biondi, A; Cazzaniga, G
Lessons after the early management of the COVID-19 outbreak in a pediatric transplant and hemato-oncology center embedded within a COVID-19 dedicated hospital in Lombardia, Italy. Estote parati
2020 Balduzzi, A; Brivio, E; Rovelli, A; Rizzari, C; Gasperini, S; Melzi, M; Conter, V; Biondi, A
Randomized post-induction and delayed intensification therapy in high-risk pediatric acute lymphoblastic leukemia: long-term results of the international AIEOP-BFM ALL 2000 trial
2020 Attarbaschi, A; Mann, G; Zimmermann, M; Bader, P; Barisone, E; Basso, G; Biondi, A; Cario, G; Cazzaniga, G; Colombini, A; Flotho, C; Kuhlen, M; Lang, P; Lauten, M; Linderkamp, C; Locatelli, F; Lo Nigro, L; Moricke, A; Niggli, F; Panzer-Grumayer, R; Parasole, R; Peters, C; Caterina Putti, M; Rizzari, C; Suttorp, M; Valsecchi, M; Conter, V; Schrappe, M
Relapses and treatment-related events contributed equally to poor prognosis in children with ABL-class fusion positive B-cell acute lymphoblastic leukemia treated according to AIEOP-BFM protocols
2020 Cario, G; Leoni, V; Conter, V; Attarbaschi, A; Zaliova, M; Sramkova, L; Cazzaniga, G; Fazio, G; Sutton, R; Elitzur, S; Izraeli, S; Lauten, M; Locatelli, F; Basso, G; Buldini, B; Bergmann, A; Lentes, J; Steinemann, D; Göhring, G; Schlegelberger, B; Haas, O; Schewe, D; Buchmann, S; Moericke, A; White, D; Revesz, T; Stanulla, M; Mann, G; Bodmer, N; Arad-Cohen, N; Zuna, J; Valsecchi, M; Zimmermann, M; Schrappe, M; Biondi, A
Long-term follow up of pediatric Philadelphia positive acute lymphoblastic leukemia treated with the EsPhALL2004 study: High white blood cell count at diagnosis is the strongest prognostic factor
2019 Biondi, A; Cario, G; De Lorenzo, P; Castor, A; Conter, V; Leoni, V; Gandemer, V; Pieters, R; Stary, J; Escherich, G; Campbell, M; Attarbaschi, A; Li, C; Vora, A; Bradtke, J; Saha, V; Valsecchi, M; Schrappe, M
Outcome of adolescent patients with acute lymphoblastic leukaemia aged 10–14 years as compared with those aged 15–17 years: Long-term results of 1094 patients of the AIEOP-BFM ALL 2000 study
2019 Testi, A; Attarbaschi, A; Valsecchi, M; Moricke, A; Cario, G; Niggli, F; Silvestri, D; Bader, P; Kuhlen, M; Parasole, R; Putti, M; Lang, P; Flotho, C; Mann, G; Rizzari, C; Barisone, E; Locatelli, F; Linderkamp, C; Lauten, M; Suttorp, M; Zimmermann, M; Basso, G; Biondi, A; Conter, V; Schrappe, M
Role of healthcare databases and registries for surveillance of orphan drugs in the real-world setting: the Italian case study
2019 Crisafulli, S; Sultana, J; Ingrasciotta, Y; Addis, A; Cananzi, P; Cavagna, L; Conter, V; D'Angelo, G; Ferrajolo, C; Mantovani, L; Pastorello, M; Scondotto, S; Trifiro, G
Imatinib treatment of paediatric Philadelphia chromosome-positive acute lymphoblastic leukaemia (EsPhALL2010): a prospective, intergroup, open-label, single-arm clinical trial
2018 Biondi, A; Gandemer, V; De Lorenzo, P; Cario, G; Campbell, M; Castor, A; Pieters, R; Baruchel, A; Vora, A; Leoni, V; Stary, J; Escherich, G; Li, C; Cazzaniga, G; Cavé, H; Bradtke, J; Conter, V; Saha, V; Schrappe, M; Grazia Valsecchi, M
Oral nutritional supplementation in children treated for cancer in low- and middle-income countries is feasible and effective: The experience of the children's hospital manuel de jesus rivera "la mascota" in Nicaragua
2018 Peccatori, N; Ortiz, R; Rossi, E; Calderon, P; Conter, V; García, Y; Biondi, A; Espinoza, D; Ceppi, F; Mendieta, L; Melzi, M
Predictive value of minimal residual disease in philadelphia-chromosome-positive acute lymphoblastic leukemia treated with imatinib in the European intergroup study of post-induction treatment of Philadelphia-chromosome-positive acute lymphoblastic leukemia, based on immunoglobulin/T-cell receptor and BCR/ABL1 methodologies
2018 Cazzaniga, G; De Lorenzo, P; Alten, J; Röttgers, S; Hancock, J; Saha, V; Castor, A; Madsen, H; Gandemer, V; Cavé, H; Leoni, V; Köhler, R; Ferrari, G; Bleckmann, K; Pieters, R; Van Der Velden, V; Stary, J; Zuna, J; Escherich, G; Stadt, U; Aricò, M; Conter, V; Schrappe, M; Valsecchi, M; Biondi, A